참고문헌
- Gurney JG, Ross JA, Wall DA, Bleyer WA, Severson RK, Robison LL. Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol 1997;19:428-32. https://doi.org/10.1097/00043426-199709000-00004
- Laverdiere C, Liu Q, Yasui Y, et al. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2009;101:1131-40. https://doi.org/10.1093/jnci/djp230
- Woods WG, Tuchman M, Bernstein ML, et al. Screening for neuroblastoma in North America: 2-year results from the Quebec Project. Am J Pediatr Hematol Oncol 1992;14:312-9. https://doi.org/10.1097/00043426-199211000-00006
- Castleberry RP, Kun LE, Shuster JJ, et al. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 1991;9:789-95. https://doi.org/10.1200/JCO.1991.9.5.789
- Wolden SL, Gollamudi SV, Kushner BH, et al. Local control with multimodality therapy for stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys 2000;46:969-74. https://doi.org/10.1016/S0360-3016(99)00399-5
- Kushner BH, Wolden S, LaQuaglia MP, et al. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 2001;19:2821-8. https://doi.org/10.1200/JCO.2001.19.11.2821
- Bradfield SM, Douglas JG, Hawkins DS, Sanders JE, Park JR. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma. Cancer 2004;100:1268-75. https://doi.org/10.1002/cncr.20091
- Casey DL, Kushner BH, Cheung NK, Modak S, LaQuaglia MP, Wolden SL. Local control with 21-Gy radiation therapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 2016;96:393-400. https://doi.org/10.1016/j.ijrobp.2016.05.020
- Ferris MJ, Danish H, Switchenko JM, et al. Favorable local control from consolidative radiation therapy in high-risk neuroblastoma despite gross residual disease, positive margins, or nodal involvement. Int J Radiat Oncol Biol Phys 2017;97:806-12. https://doi.org/10.1016/j.ijrobp.2016.11.043
- Gatcombe HG, Marcus RB Jr, Katzenstein HM, Tighiouart M, Esiashvili N. Excellent local control from radiation therapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 2009;74:1549-54. https://doi.org/10.1016/j.ijrobp.2008.10.069
- Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-77. https://doi.org/10.1200/JCO.1993.11.8.1466
- Seif AE, Naranjo A, Baker DL, et al. A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1. Bone Marrow Transplant 2013;48:947-52. https://doi.org/10.1038/bmt.2012.276
- Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 1999;341:1165-73. https://doi.org/10.1056/NEJM199910143411601
- Halperin EC. Long-term results of therapy for stage C neuroblastoma. J Surg Oncol 1996;63:172-8. https://doi.org/10.1002/(SICI)1096-9098(199611)63:3<172::AID-JSO7>3.0.CO;2-A
- Matthay KK, Atkinson JB, Stram DO, Selch M, Reynolds CP, Seeger RC. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Children's Cancer Group pilot study. J Clin Oncol 1993;11:2226-33. https://doi.org/10.1200/JCO.1993.11.11.2226
- Haase GM, O'Leary MC, Ramsay NK, et al. Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg 1991;26:1119-24. https://doi.org/10.1016/0022-3468(91)90686-N
- Casey DL, Kushner BH, Cheung NV, Modak S, LaQuaglia MP, Wolden SL. Dose-escalation is needed for gross disease in high-risk neuroblastoma. Pediatr Blood Cancer 2018;65:e27009. https://doi.org/10.1002/pbc.27009
- Haas-Kogan DA, Swift PS, Selch M, et al. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study. Int J Radiat Oncol Biol Phys 2003;56:28-39. https://doi.org/10.1016/S0360-3016(02)04506-6
- Pai Panandiker AS, McGregor L, Krasin MJ, Wu S, Xiong X, Merchant TE. Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma. Int J Radiat Oncol Biol Phys 2010;76:1161-5. https://doi.org/10.1016/j.ijrobp.2009.03.068
- LaQuaglia MP, Kushner BH, Heller G, Bonilla MA, Lindsley KL, Cheung NK. Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg 1994;29:1162-6. https://doi.org/10.1016/0022-3468(94)90301-8
- Casey DL, Pitter KL, Kushner BH, et al. Radiation therapy to sites of metastatic disease as part of consolidation in highrisk neuroblastoma: can long-term control be achieved? Int J Radiat Oncol Biol Phys 2018;100:1204-9. https://doi.org/10.1016/j.ijrobp.2018.01.008
- Li R, Polishchuk A, DuBois S, et al. Patterns of relapse in high-risk neuroblastoma patients treated with and without total body irradiation. Int J Radiat Oncol Biol Phys 2017;97:270-7. https://doi.org/10.1016/j.ijrobp.2016.10.047
- Mazloom A, Louis CU, Nuchtern J, et al. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 2014;90:858-62. https://doi.org/10.1016/j.ijrobp.2014.07.019
- Polishchuk AL, Li R, Hill-Kayser C, et al. Likelihood of bone recurrence in prior sites of metastasis in patients with highrisk neuroblastoma. Int J Radiat Oncol Biol Phys 2014;89:839-45. https://doi.org/10.1016/j.ijrobp.2014.04.004
- Sibley GS, Mundt AJ, Goldman S, et al. Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma. Int J Radiat Oncol Biol Phys 1995;32:1127-35. https://doi.org/10.1016/0360-3016(95)00011-M
- George RE, Li S, Medeiros-Nancarrow C, et al. High-risk neuroblastoma treated with tandem autologous peripheralblood stem cell-supported transplantation: long-term survival update. J Clin Oncol 2006;24:2891-6. https://doi.org/10.1200/JCO.2006.05.6986
피인용 문헌
- Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification vol.39, pp.1, 2019, https://doi.org/10.1186/s40880-019-0409-1
- Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry vol.10, 2021, https://doi.org/10.3389/fonc.2020.617506